APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dimethyl Fumarate Delayed-release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dimethyl Fumarate Delayed-release Capsules Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchDimethyl Fumarate Delayed-release Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dimethyl Fumarate Delayed-release Capsules Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Dimethyl Fumarate Delayed-release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dimethyl Fumarate Delayed-release Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dimethyl Fumarate Delayed-release Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dimethyl Fumarate Delayed-release Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dimethyl Fumarate Delayed-release Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dimethyl Fumarate Delayed-release Capsules market include Teva Pharmaceutical, Sichuan Omnis Pharmaceutical, Qilu Pharmaceutical, Mylan, Polpharma, Neuraxpharm, Lupin, Hexal AG and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dimethyl Fumarate Delayed-release Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dimethyl Fumarate Delayed-release Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dimethyl Fumarate Delayed-release Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dimethyl Fumarate Delayed-release Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Dimethyl Fumarate Delayed-release Capsules Segment by Company

Teva Pharmaceutical

Sichuan Omnis Pharmaceutical

Qilu Pharmaceutical

Mylan

Polpharma

Neuraxpharm

Lupin

Hexal AG

Glenmark Pharmaceuticals

Cipla

Biogen

Accord Healthcare

Dimethyl Fumarate Delayed-release Capsules Segment by Type

120mg per Unit

240mg per Unit

Dimethyl Fumarate Delayed-release Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Dimethyl Fumarate Delayed-release Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dimethyl Fumarate Delayed-release Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dimethyl Fumarate Delayed-release Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dimethyl Fumarate Delayed-release Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Dimethyl Fumarate Delayed-release Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dimethyl Fumarate Delayed-release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dimethyl Fumarate Delayed-release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dimethyl Fumarate Delayed-release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dimethyl Fumarate Delayed-release Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dimethyl Fumarate Delayed-release Capsules industry.

Chapter 3: Detailed analysis of Dimethyl Fumarate Delayed-release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dimethyl Fumarate Delayed-release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dimethyl Fumarate Delayed-release Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dimethyl Fumarate Delayed-release Capsules Industry Trends Table 2. Dimethyl Fumarate Delayed-release Capsules Industry Drivers Table 3. Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges Table 4. Dimethyl Fumarate Delayed-release Capsules Industry Restraints Table 5. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dimethyl Fumarate Delayed-release Capsules Revenue Share by Company (2021-2026) Table 7. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Dimethyl Fumarate Delayed-release Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dimethyl Fumarate Delayed-release Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dimethyl Fumarate Delayed-release Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Dimethyl Fumarate Delayed-release Capsules Company, Product Type & Application Table 13. Global Dimethyl Fumarate Delayed-release Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dimethyl Fumarate Delayed-release Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 120mg per Unit Table 18. Significant Companies of 240mg per Unit Table 19. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type (2021-2026) Table 28. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Other Table 32. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application (2021-2026) Table 41. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application (2027-2032) Table 42. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2021-2026) Table 45. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2027-2032) Table 47. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Region (2021-2026) Table 50. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Region (2027-2032) Table 52. Global Dimethyl Fumarate Delayed-release Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Dimethyl Fumarate Delayed-release Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Dimethyl Fumarate Delayed-release Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 57. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2021-2026) Table 58. Global Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2027-2032) Table 60. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical Company Information Table 65. Teva Pharmaceutical Business Overview Table 66. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 68. Teva Pharmaceutical Recent Development Table 69. Sichuan Omnis Pharmaceutical Company Information Table 70. Sichuan Omnis Pharmaceutical Business Overview Table 71. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 73. Sichuan Omnis Pharmaceutical Recent Development Table 74. Qilu Pharmaceutical Company Information Table 75. Qilu Pharmaceutical Business Overview Table 76. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 78. Qilu Pharmaceutical Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 83. Mylan Recent Development Table 84. Polpharma Company Information Table 85. Polpharma Business Overview Table 86. Polpharma Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 88. Polpharma Recent Development Table 89. Neuraxpharm Company Information Table 90. Neuraxpharm Business Overview Table 91. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 93. Neuraxpharm Recent Development Table 94. Lupin Company Information Table 95. Lupin Business Overview Table 96. Lupin Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 98. Lupin Recent Development Table 99. Hexal AG Company Information Table 100. Hexal AG Business Overview Table 101. Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 103. Hexal AG Recent Development Table 104. Glenmark Pharmaceuticals Company Information Table 105. Glenmark Pharmaceuticals Business Overview Table 106. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 108. Glenmark Pharmaceuticals Recent Development Table 109. Cipla Company Information Table 110. Cipla Business Overview Table 111. Cipla Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 113. Cipla Recent Development Table 114. Biogen Company Information Table 115. Biogen Business Overview Table 116. Biogen Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 118. Biogen Recent Development Table 119. Accord Healthcare Company Information Table 120. Accord Healthcare Business Overview Table 121. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 123. Accord Healthcare Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Dimethyl Fumarate Delayed-release Capsules Distributors List Table 127. Dimethyl Fumarate Delayed-release Capsules Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Dimethyl Fumarate Delayed-release Capsules Product Image Figure 2. Global Dimethyl Fumarate Delayed-release Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dimethyl Fumarate Delayed-release Capsules Sales (2021-2032) & (K Units) Figure 5. Global Dimethyl Fumarate Delayed-release Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dimethyl Fumarate Delayed-release Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 120mg per Unit Image Figure 10. 240mg per Unit Image Figure 11. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dimethyl Fumarate Delayed-release Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dimethyl Fumarate Delayed-release Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg per Unit
  • 240mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva Pharmaceutical
  • Sichuan Omnis Pharmaceutical
  • Qilu Pharmaceutical
  • Mylan
  • Polpharma
  • Neuraxpharm
  • Lupin
  • Hexal AG
  • Glenmark Pharmaceuticals
  • Cipla
  • Biogen
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dimethyl Fumarate Delayed-release Capsules Market Dynamics
  1. 2.1 Dimethyl Fumarate Delayed-release Capsules Industry Trends
  2. 2.2 Dimethyl Fumarate Delayed-release Capsules Industry Drivers
  3. 2.3 Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges
  4. 2.4 Dimethyl Fumarate Delayed-release Capsules Industry Restraints
3 Dimethyl Fumarate Delayed-release Capsules Market by Company
  1. 3.1 Global Dimethyl Fumarate Delayed-release Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Dimethyl Fumarate Delayed-release Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Dimethyl Fumarate Delayed-release Capsules Company Ranking (2024-2026)
  6. 3.6 Global Dimethyl Fumarate Delayed-release Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Dimethyl Fumarate Delayed-release Capsules Company Product Type and Application
  8. 3.8 Global Dimethyl Fumarate Delayed-release Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dimethyl Fumarate Delayed-release Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dimethyl Fumarate Delayed-release Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dimethyl Fumarate Delayed-release Capsules Market by Type
  1. 4.1 Dimethyl Fumarate Delayed-release Capsules Type Introduction
  2. 4.1.1 120mg per Unit
  3. 4.1.2 240mg per Unit
  4. 4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type
  5. 4.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type
  9. 4.3.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type (2021-2032)
5 Dimethyl Fumarate Delayed-release Capsules Market by Application
  1. 5.1 Dimethyl Fumarate Delayed-release Capsules Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application
  6. 5.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application
  10. 5.3.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application (2021-2032)
6 Dimethyl Fumarate Delayed-release Capsules Regional Sales and Value Analysis
  1. 6.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2027-2032)
  5. 6.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Dimethyl Fumarate Delayed-release Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dimethyl Fumarate Delayed-release Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Country, 2025 VS 2032
7 Dimethyl Fumarate Delayed-release Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032)
  6. 7.4 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dimethyl Fumarate Delayed-release Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dimethyl Fumarate Delayed-release Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sichuan Omnis Pharmaceutical
  8. 8.2.1 Sichuan Omnis Pharmaceutical Company Information
  9. 8.2.2 Sichuan Omnis Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  12. 8.2.5 Sichuan Omnis Pharmaceutical Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Polpharma
  26. 8.5.1 Polpharma Company Information
  27. 8.5.2 Polpharma Business Overview
  28. 8.5.3 Polpharma Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  30. 8.5.5 Polpharma Recent Developments
  31. 8.6 Neuraxpharm
  32. 8.6.1 Neuraxpharm Company Information
  33. 8.6.2 Neuraxpharm Business Overview
  34. 8.6.3 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  36. 8.6.5 Neuraxpharm Recent Developments
  37. 8.7 Lupin
  38. 8.7.1 Lupin Company Information
  39. 8.7.2 Lupin Business Overview
  40. 8.7.3 Lupin Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  42. 8.7.5 Lupin Recent Developments
  43. 8.8 Hexal AG
  44. 8.8.1 Hexal AG Company Information
  45. 8.8.2 Hexal AG Business Overview
  46. 8.8.3 Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  48. 8.8.5 Hexal AG Recent Developments
  49. 8.9 Glenmark Pharmaceuticals
  50. 8.9.1 Glenmark Pharmaceuticals Company Information
  51. 8.9.2 Glenmark Pharmaceuticals Business Overview
  52. 8.9.3 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  54. 8.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 Biogen
  62. 8.11.1 Biogen Company Information
  63. 8.11.2 Biogen Business Overview
  64. 8.11.3 Biogen Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  66. 8.11.5 Biogen Recent Developments
  67. 8.12 Accord Healthcare
  68. 8.12.1 Accord Healthcare Company Information
  69. 8.12.2 Accord Healthcare Business Overview
  70. 8.12.3 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  72. 8.12.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dimethyl Fumarate Delayed-release Capsules Value Chain Analysis
  2. 9.1.1 Dimethyl Fumarate Delayed-release Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dimethyl Fumarate Delayed-release Capsules Sales Mode & Process
  6. 9.2 Dimethyl Fumarate Delayed-release Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dimethyl Fumarate Delayed-release Capsules Distributors
  9. 9.2.3 Dimethyl Fumarate Delayed-release Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst